Antibe Therapeutics Inc (ATBPF)
0.2156
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Antibe Therapeutics Shareholders Equity (Quarterly): 19.55M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.55M |
| September 30, 2023 | 21.86M |
| June 30, 2023 | 26.26M |
| March 31, 2023 | 29.70M |
| December 31, 2022 | 31.88M |
| September 30, 2022 | 34.20M |
| June 30, 2022 | 40.39M |
| March 31, 2022 | 45.52M |
| December 31, 2021 | 48.02M |
| September 30, 2021 | 50.68M |
| June 30, 2021 | 57.85M |
| March 31, 2021 | 39.82M |
| December 31, 2020 | 13.26M |
| September 30, 2020 | 16.93M |
| June 30, 2020 | 22.53M |
| March 31, 2020 | 2.665M |
| December 31, 2019 | 5.308M |
| September 30, 2019 | 6.845M |
| June 30, 2019 | 4.106M |
| March 31, 2019 | 5.573M |
| December 31, 2018 | 4.184M |
| September 30, 2018 | 4.916M |
| Date | Value |
|---|---|
| June 30, 2018 | 5.939M |
| March 31, 2018 | 6.176M |
| December 31, 2017 | 2.603M |
| September 30, 2017 | 3.867M |
| June 30, 2017 | 4.273M |
| March 31, 2017 | 2.665M |
| December 31, 2016 | 3.857M |
| September 30, 2016 | 3.158M |
| June 30, 2016 | 3.985M |
| March 31, 2016 | 3.627M |
| December 31, 2015 | 3.808M |
| September 30, 2015 | 0.3512M |
| June 30, 2015 | 0.925M |
| March 31, 2015 | 0.266M |
| December 31, 2014 | 0.8133M |
| September 30, 2014 | 1.573M |
| June 30, 2014 | 2.731M |
| March 31, 2014 | 3.002M |
| December 31, 2013 | 0.9803M |
| September 30, 2013 | 1.151M |
| June 30, 2013 | 0.9414M |
| March 31, 2013 | -0.9909M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.665M
Minimum
Mar 2020
57.85M
Maximum
Jun 2021
27.23M
Average
26.26M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| InMed Pharmaceuticals Inc | 11.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 42.49M |
| Total Liabilities (Quarterly) | 22.93M |